Previous close | 18.05 |
Open | 17.81 |
Bid | 17.80 x 3000 |
Ask | 17.83 x 3000 |
Day's range | 17.62 - 17.98 |
52-week range | 17.51 - 35.38 |
Volume | |
Avg. volume | 12,825,348 |
Market cap | 15.365B |
Beta (5Y monthly) | 0.75 |
PE ratio (TTM) | N/A |
EPS (TTM) | -7.00 |
Earnings date | 25 June 2024 - 01 July 2024 |
Forward dividend & yield | 1.00 (5.61%) |
Ex-dividend date | 16 Feb 2024 |
1y target est | 22.71 |
(Bloomberg) -- Walgreens Boots Alliance Inc. is opening a new center dedicated to bringing emerging cell and gene therapies to patients with complex, chronic conditions like cancer, cystic fibrosis and Crohn’s disease.Most Read from BloombergBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsMalaysia in Talks With Tycoons on Casino to Revive $100 Billion Forest CityZuckerberg Asks for Patience as Meta’s AI Push Spooks InvestorsMeta’s Miss Sparks Fears in Tech With More Earn
DEERFIELD, Ill., April 25, 2024--Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its core pharmacy business to improve patient outcomes and provide greater value to payers and partners. The company today introduced Walgreens Specialty Pharmacy, a holistic offering that expands access to care for patients with complex, chronic conditions and enables partnerships that drive profitability for Walgreens’ pharmacy business. The com
SAN FRANCISCO, April 24, 2024--DoorDash (NASDAQ: DASH), the local commerce platform, and Walgreens (NASDAQ: WBA), a trusted, neighborhood health destination serving nearly 10 million customers each day, today announced a new collaboration to offer SNAP/EBT payment at nearly 7,800 Walgreens stores across the country. DoorDash is the first platform that enables SNAP customers to make purchases directly from Walgreens using their SNAP/EBT cards. In addition, DoorDash is the first third-party delive